Evidence map›Paper›PMID 36124309›Full record

ArticlePatterns (New York, N.Y.)2022

Knowledge-guided deep learning models of drug toxicity improve interpretation.

Yun Hao, Joseph D Romano, Jason H Moore

Open access · goldAbstract read
In one paragraph

Article in Patterns (New York, N.Y.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Pathway-guided architectures for interpretable AI in biological research.Computational and structural biotechnology journal · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Acta pharmaceutica Sinica. B · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Yun HaoGenomics and Computational Biology (GCB) Graduate Program, University of Pennsylvania, Philadelphia, PA, USA.
Joseph D RomanoInstitute for Biomedical Informatics, University of Pennsylvania, Philadelphia, PA, USA.
Jason H MooreDepartment of Computational Biomedicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
University of Pennsylvania · USCedars-Sinai Medical Center · US

Funding

Translational Research Support CoreP30ES013508 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI A. Clementina Mesaros · 2006 to 2026
$35.3M
Artificial Intelligence Strategies for Alzheimer's Disease ResearchR01AG066833 · NIA · UNIVERSITY OF PENNSYLVANIA · PI MOORE, JASON H., RITCHIE, MARYLYN D · 2021 to 2021
$1.6M
Discovering clinical endpoints of toxicity via graph machine learning and semantic data analysisR00LM013646 · NLM · UNIVERSITY OF PENNSYLVANIA · PI ROMANO, JOSEPH DANIEL · 2023 to 2025
$646k
Discovering clinical endpoints of toxicity via graph machine learning and semantic data analysisK99LM013646 · NLM · UNIVERSITY OF PENNSYLVANIA · PI ROMANO, JOSEPH DANIEL · 2021 to 2022
$183k
NIA NIH HHS R01 AG066833NIEHS NIH HHS P30 ES013508NLM NIH HHS K99 LM013646NLM NIH HHS R00 LM013646
6 · The paper itself

Abstract

In drug development, a major reason for attrition is the lack of understanding of cellular mechanisms governing drug toxicity. The black-box nature of conventional classification models has limited their utility in identifying toxicity pathways. Here we developed DTox (deep learning for toxicology), an interpretation framework for knowledge-guided neural networks, which can predict compound response to toxicity assays and infer toxicity pathways of individual compounds. We demonstrate that DTox can achieve the same level of predictive performance as conventional models with a significant improvement in interpretability. Using DTox, we were able to rediscover mechanisms of transcription activation by three nuclear receptors, recapitulate cellular activities induced by aromatase inhibitors and pregnane X receptor (PXR) agonists, and differentiate distinctive mechanisms leading to HepG2 cytotoxicity. Virtual screening by DTox revealed that compounds with predicted cytotoxicity are at higher risk for clinical hepatic phenotypes. In summary, DTox provides a framework for deciphering cellular mechanisms of toxicity

Indexed as

deep learningdrug toxicitymodel interpretationmolecular toxicology

Identifiers

PMID36124309
PMCPMC9481960
OpenAlexW4293212631

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.